Picture of Anterogen Co logo

065660 Anterogen Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for Anterogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4,1518,1226,5916,5006,933
Cost of Revenue
Gross Profit1,7423,8722,6162,6662,628
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses6,89310,75511,22111,95710,738
Operating Profit-2,742-2,633-4,630-5,457-3,805
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-4,375-554-6,850-2,841-2,293
Provision for Income Taxes
Net Income After Taxes-4,375-554-6,837-2,841-2,293
Net Income Before Extraordinary Items
Net Income-4,375-554-6,837-2,841-2,293
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-4,375-554-6,837-2,841-2,293
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-588-95.6-709-253-230
Dividends per Share